Abstract:In the past, drug discovery using low-molecular-weight compounds was dominated by structural design based on combinations of non-metallic elements such as carbon, nitrogen, oxygen, and halogens. Recent drug discovery efforts have shown extraordinary progress, an example of which is the adoption of non-universal elements. The approval of boron neutron capture therapy (BNCT) using a neutron accelerator in Japan ahead of other countries is still fresh in our memory. Other small-molecule drugs containing boron atoms have also been developed, and boron is becoming widely recognized as a constituent element for drug discovery. It is known that borane (BH3) is unstable because of its electron-deficient bonds; nevertheless, its stability has been improved by the formation of clusters through multimerization. Carborane (C2B10H12), one of the borane clusters, has an icosahedral structure with two carbon atoms and ten boron atoms and exhibits properties that vastly differ from conventional boron compounds. In this symposium review, we will introduce the basic chemistry of carboranes and their application to drug discovery. Boron is an essential element in plant cell wall formation and has extremely low toxicity to humans. I hope that this symposium review will be an opportunity for us to free ourselves from existing prejudices and constraints in drug discovery, and that new modalities that skillfully utilize the characteristics of boron and boron clusters will be developed one after another.

The Boron Advantage: The Evolution and Diversification of Boron’s Applications in Medicinal Chemistry

Boron Chemistry for Medical Applications

[Basic Organic and Inorganic Chemistry of Boron Clusters and Its Application to Drug Discovery].

Recent developments in the medicinal chemistry of single boron atom-containing compounds

Boron in cancer therapeutics: An overview

The Rise of Boron-Containing Compounds: Advancements in Synthesis, Medicinal Chemistry, and Emerging Pharmacology

Carboranes in drug discovery, chemical biology and molecular imaging

Recent Advances in B–H Functionalization of Icosahedral Carboranes and Boranes by Transition Metal Catalysis

Towards the Application of Purely Inorganic Icosahedral Boron Clusters in Emerging Nanomedicine

Development History of Boron Delivery Agents

Sweet Boron: Boron-Containing Sugar Derivatives as Potential Agents for Boron Neutron Capture Therapy

Merging Boron with Nitrogen–Oxygen Bonds: A Review on BON Heterocycles

Optimizing Boron Neutron Capture Therapy (BNCT) to Treat Cancer: An Updated Review on the Latest Developments on Boron Compounds and Strategies

Boron nanoparticles in chemotherapy and radiotherapy: the synthesis, state-of-the-art, and prospects

1,2‐Boryl Migration Enables Efficient Access to Versatile Functionalized Boronates

Nanostructured boron agents for boron neutron capture therapy: a review of recent patents

Boron‐Stereogenic Compounds: Synthetic Developments and Opportunities

New Boron Delivery Agents

A periodic development of BPA and BSH based derivatives in boron neutron capture therapy (BNCT)

Next-Generation Boron Drugs and Rational Translational Studies Driving the Revival of BNCT

Multi-Functional Boron-Delivery Agents for Boron Neutron Capture Therapy of Cancers